Men with endangered prostate cancer in the United States, also use the watch-and-fan approach, also known as "active surveillance" in 2015, up from 14.5% in 2010, of According to studies published in the JAMA medical journal on Monday.
Compared to high risk prostate cancer or intermediate risk, prostate cancer is highly affected by low risk, which is why "active surveillance" can be considered as an alternative to the treatment of options such as surgery or radiation therapy . Surgery and radiotherapy can get some side effects, including a higher risk of construction or accidental urine or stomach leakage problems.
Given that active surveillance carried out between 201
0 and 2015 was used, the most common way to manage a low risk of prostate cancer, according to the study.
"The use of active surveillance was found at risk of low-risk prostate cancer," said Dr. Brandon Mahal, a clinical person in radiation oncology at the Dana-Farber Cancer Cancer Institute in Boston and the first author of the study .
"Overall, it's a good sign and these things," he said. "From 2010 to 2015, there is a lot of new evidence – the highest level of evidence we can obtain in medicine, with prospective trials and some random tests – showing active surveillance, conservative or non-verbal Preventative results at a low-risk prostate cancer treatment approach. "
& # 39; This study is actually the benchmark & # 39;
In the world, prostate cancer is the second most common cancer among men. 1.3 million new prostate cancer cases say in 2018, says the World Cancer Research Fund.
In the United States, 11.2% of men with prostate cancer have been diagnosed at some point during their lives, according to the National Cancer Institute.
Include the study New data on 164,760 men diagnosed with prostate cancer in the United States between 2010 and 2015. The data, derived from the Surveillance database, Epidemiology, and Results Results, included the treatment approach of each man.
The researchers found that the use of active surveillance increased when radical prostatectomy – or parts of the prostate gland – increased from 47.4% in 2010 to 31.3% in 2015. Radiotherapy was also reduced by drop from 38% in 2010 to 26.6% in 2015, researchers found out.
Men with an intermediate risk disease, between 2010 and 2015, have increased from 5.8% to 9.6% on active surveillance; prostatectomy decreased from 51.8% to 50.6%; and radiotherapy went from 42.4% to 39.8%, found by researchers.
Men with a high risk disease, active surveillance did not change almost unchanged, ranging from 1.9% to 2.2%; prostatectomy increased from 38% to 42.8%; and radiotherapy reduced from 60.1% to 55%, found by researchers.